Thelansis

  Neuroendocrine carcinoma (NEC) is an infrequent malignancy originating from neuroendocrine cells, which are distributed throughout the body and secrete hormones that regulate physiological functions such as digestion, cardiovascular activity, and sleep. NECs can develop in various anatomical locations, including the gastrointestinal tract, lungs, pancreas, endocrine glands, skin, reproductive organs, adrenal glands, breast, ovaries or testes, and kidneys. Neuroendocrine carcinomas encompass a range of neoplasms with differing degrees of malignancy and aggressiveness, categorized into typical (low-grade) and atypical carcinoids (intermediate-grade), large cell neuroendocrine carcinoma (intermediate-grade), and small cell lung carcinoma (SCLC) (high-grade). Risk factors for neuroendocrine tumors (NETs) include hereditary cancer syndromes, such as von Hippel-Lindau disease, and other genetic conditions like multiple endocrine neoplasia and neurofibromatosis type 1. Neuroendocrine ...